Inotiv, Inc. to Participate in Upcoming Investor Conferences
16 mai 2022 08h53 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 16, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results
12 mai 2022 17h18 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 12, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Report Second Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, May 12, 2022
26 avr. 2022 16h35 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 26, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical...
Inotiv, Inc. Bolsters Pathology Services with Acquisition of Histion, LLC
25 avr. 2022 14h00 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 25, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical...
Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
30 mars 2022 07h50 HE
|
Vyant Bio, Inc.
Highlights Focused as a pure-play drug discovery and development biotechnology companyPrimary work on the discovery of small molecule therapeutics to treat neurodevelopmental and neurodegenerative...
Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results
10 févr. 2022 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Report First Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, February 10, 2022
27 janv. 2022 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc.
27 janv. 2022 12h00 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces the Acquisition of the Rabbit Breeding and Supply Business of Robinson Services Inc. (“RSI”)
06 janv. 2022 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers
04 janv. 2022 08h33 HE
|
Inotiv, Inc.
-- Expected to establish a leading global provider of full-spectrum, preclinical and clinical biotherapeutics and biomarker analysis solutions -- -- Expected to enhance scale, broaden customer base...